World Journal of Pediatrics

, Volume 6, Issue 2, pp 103–110 | Cite as

Management of subependymal giant cell tumors in tuberous sclerosis complex: the neurosurgeon’s perspective

Review Article



Tuberous sclerosis complex (TSC), an autosomal dominant genetic disorder, can lead to the development of hamartomas in various organs, including the heart, lungs, kidneys, skin and brain. The management of subependymal giant cell tumors (SGCTs) is still controversial, and peri- and/or intraventricular neoplasms may lead to life-threatening hydrocephalus. In the last years, many progresses have been made in research into the tumorigenesis and behaviors of SGCTs. This review aims to clarify the specific role of neurosurgeons in the multidisciplinary management of SGCTs in children with TSC.

Data sources

Based on the recent scientific literature and personal experience, we reviewed the up-to-date data and discussed the trends in the management of SGCTs in children with TSC. The data were collected after a bibliography made using PubMed/Medline with these terms: subependymal, subependymal giant cell astrocytoma, subependymal giant cell tumor, and tuberous sclerosis complex.


SGCTs are shown to be generated from a glioneuronal lineage, but their filiation with subependymal nodules (SENs) is still under debate. While SENs may develop anywhere in the ventricular walls, SGCTs arise almost exclusively around the Monro foramina. In children with TSC, precise clinical and/or imaging criteria are mandatory to differentiate SENs that are always asymptomatic and riskless from SGCTs that have the potential to grow and therefore to obstruct cerebrospinal fluid pathways leading to hydrocephalus.


An earlier diagnosis of SGCT in neurologically asymptomatic children with TSC may allow a precocious surgical removal of the tumor before the installation of increased intracranial pressure signs, an attitude that is being progressively adopted to lessen the morbimortality rate.

Key words

cerebral ventricle hydrocephalus intraventricular tumor microsurgery subependymal giant cell astrocytoma tuberous sclerosis 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Ribaupierre S, Dorfmüller G, Bulteau C, Fohlen M, Pinard JM, Chiron C, et al. Subependymal giant-cell astrocytomas in paediatric tuberous sclerosis disease: When should we operate? Neurosurgery 2007;60:83–90.PubMedGoogle Scholar
  2. 2.
    Griffiths PD, Martland TR. Tuberous sclerosis complex: the role of neuroradiology. Neuropediatrics 1997;28:244–252.CrossRefPubMedGoogle Scholar
  3. 3.
    Cuccia V, Zuccaro G, Sosa F, Monges J, Lubienieky F, Taratuto A. Subependymal giant cell tumor in children with tuberous sclerosis. Childs Nerv Syst 2003;19:232–243.PubMedGoogle Scholar
  4. 4.
    Osborne JP, Fryer A, Webb D. Epidemiology of tuberous sclerosis. Ann N Y Acad Sci 1991;615:125–127.CrossRefPubMedGoogle Scholar
  5. 5.
    Joinson C, O’Callaghan FJ, Osborne JP, Martyn C, Harris T, Bolton PF. Learning disability and epilepsy in an epidemiological sample of individuals with tuberous sclerosis complex. Psychol Med 2003;33:335–344.CrossRefPubMedGoogle Scholar
  6. 6.
    Webb DW, Fryer AE, Osborne JP. Morbidity associated with tuberous sclerosis: a population study. Dev Med Child Neurol 1996;38:146–155.PubMedCrossRefGoogle Scholar
  7. 7.
    Jozwiak J, Jozwiak S, Wlodarski P. Possible mechanisms of disease development in tuberous sclerosis. Lancet Oncol 2008;9:73–79.CrossRefPubMedGoogle Scholar
  8. 8.
    Roszkowski M, Drabik K, Barszcz S, Jozwiak S. Surgical treatment of intraventricular tumors associated with tuberous sclerosis. Childs Nerv Syst 1995;11:335–339.CrossRefPubMedGoogle Scholar
  9. 9.
    Nabbout R, Santos M, Rolland Y, Delalande O, Dulac O, Chiron C. Early diagnosis of subependymal giant cell tumor in children with tuberous sclerosis. J Neurol Neurosurg Psychiatry 1999;66:370–375.CrossRefPubMedGoogle Scholar
  10. 10.
    Goh S, Butler W, Thiele EA. Subependymal giant cell tumours in tuberous sclerosis complex. Neurology 2004;63:1457–1461.PubMedGoogle Scholar
  11. 11.
    Narayanan V. Tuberous sclerosis complex: genetics to pathogenesis. Pediatr Neurol 2003;29:404–409.CrossRefPubMedGoogle Scholar
  12. 12.
    Kim SK, Wang KC, Cho BK, Jung HW, Lee YJ, Chung YS, et al. Biological behaviour and tumorigenesis of subependymal giant cell astrocytomas. J Neurooncol 2001;52:217–225.CrossRefPubMedGoogle Scholar
  13. 13.
    Di Rocco C, Iannelli A, Marchese E. On the treatment of subependymal giant cell astrocytomas and associated hydrocephalus in tuberous sclerosis. Pediatr Neurosurg 1995;23:115–121.CrossRefPubMedGoogle Scholar
  14. 14.
    Gomez MR. Criteria for diagnosis. In: Gomez MR, eds. Tuberous sclerosis. New York: Raven Press, 1998:9–20.Google Scholar
  15. 15.
    Hyman MH, Whittemore VH. National Institutes of Health consensus conference: tuberous sclerosis complex. Arch Neurol 2000;57:662–665.CrossRefPubMedGoogle Scholar
  16. 16.
    O’Callaghan FJ, Harris T, Joinson C, Bolton P, Noakes M, Presdee D, et al. The relation of infantile spasms, tubers, and intelligence in tuberous sclerosis complex. Arch Dis Child 2004;89:530–533.CrossRefPubMedGoogle Scholar
  17. 17.
    Braffman BH, Bilaniuk LT, Naidich TP, Altman NR, Post MJ, Quencer RM, et al. MR imaging of tuberous sclerosis: pathogenesis of this phakomatosis, use of gadopentetate dimeglumine, and literature review. Radiology 1992;183:227–238.PubMedGoogle Scholar
  18. 18.
    Menor F, Martí-Bonmatí L, Mulas F, Poyatos C, Cortina H. Neuroimaging in tuberous sclerosis: a clinicoradiological evaluation in pediatric patients. Pediatr Radiol 1992;22:485–489.CrossRefPubMedGoogle Scholar
  19. 19.
    Hancock E, Osborne JP, Milner P. The treatment of West syndrome: a Cochrane review of the literature to December 2000. Brain Dev 2001;23:624–634.CrossRefPubMedGoogle Scholar
  20. 20.
    Romanelli P, Verdecchia M, Rodas R, Seri S, Curatolo P. Epilepsy surgery for tuberous sclerosis. Pediatr Neurol 2004;31:239–247.CrossRefPubMedGoogle Scholar
  21. 21.
    Madhavan D, Schaffer S, Yankovsky A, Arzimanoglou A, Renaldo F, Zaroff CM, et al. Surgical outcome in tuberous sclerosis complex: a multicenter survey. Epilepsia 2007;48:1625–1628.CrossRefPubMedGoogle Scholar
  22. 22.
    Jozwiak S, Kotulska K, Kasprzyk-obara J, Domańska-Pakieła D, Tomyn-Drabik M, Roberts P, et al. Clinical and genotype studies of cardiac tumors in 154 patients with tuberous sclerosis complex. Pediatrics 2006;118:1146–1151.CrossRefGoogle Scholar
  23. 23.
    Hancock E, Osborne J. Lymphangioleiomyomatosis: a review of the literature. Respir Med 2002;96:1–6.CrossRefPubMedGoogle Scholar
  24. 24.
    O’Callaghan FJ, Noakes MJ, Martyn C, Osborne JP. An epidemiological study of renal pathology in tuberous sclerosis complex. BJU Int 2004;94:853–857.CrossRefPubMedGoogle Scholar
  25. 25.
    Brook-Carter P, Peral B, Ward CJ, Thompson P, Hughes J, Maheshwar MM, et al. Deletion of the TSC2 and pKD1 genes associated with severe infantile polycystic kidney disease—a contiguous gene syndrome. Nat Genet 1994;8:328–332.CrossRefPubMedGoogle Scholar
  26. 26.
    Rose V, Au K, Pollom G, Roach ES, Prashner HR, Northrup H. Germ-line mosaicism in tuberous sclerosis: how common? Am J Hum Genet 1999;64:986–992.CrossRefPubMedGoogle Scholar
  27. 27.
    Fryer A, Chalmers A, Connor J, Fraser I, Povey S, Yates AD, et al. Evidence that the gene for tuberous sclerosis is on chromosome 9. Lancet 1987;1:659–661.CrossRefPubMedGoogle Scholar
  28. 28.
    Kandt R, Haines Jl, Smith M, Northrup H, Gardner RJ, Short MP, et al. Linkage of an important gene locus for tuberous sclerosis to a chromosome 16 marker for polycystic kidney disease. Nat Genet 1992;2:37–41.CrossRefPubMedGoogle Scholar
  29. 29.
    van Slegtenhorst M, de Hoogt R, Hermans C, Nellist M, Janssen B, Verhoef S, et al. Identification of the tuberous sclerosis gene TSC1 on chromosome 9q34. Science 1997;277:805–808.CrossRefPubMedGoogle Scholar
  30. 30.
    Dabora SL, Jozwiak S, Franz DN, Roberts PS, Nieto A, Chung J, et al. Mutational analysis in a cohort of 224 tuberous sclerosis patients indicates increased severity of TSC2, compared with TSC1, disease in multiple organs. Am J Hum Genet 2001;68:64–80.CrossRefPubMedGoogle Scholar
  31. 31.
    Jones AC, Daniells CE, Snell RG, Tachataki M, Idziaszczyk SA, Krawczak M, et al. Molecular genetic and phenotypic analysis reveals differences between TSC1 and TSC2 associated familial and sporadic tuberous sclerosis. Hum Mol Genet 1997;6:2155–2161.CrossRefPubMedGoogle Scholar
  32. 32.
    Kwiatkowska J, Wigowska-Sowinska J, Napierala D, Slomski R, Kwiatkowski DJ. Mosaicism in tuberous sclerosis as a potential cause of the failure of molecular diagnosis. N Engl J Med 1999;340:703–707.CrossRefPubMedGoogle Scholar
  33. 33.
    van Slegtenhorst M, Nellist M, Nagelkerken B, Cheadle J, Snell R, van den Ouweland A, et al. Interaction between hamartin and tuberin, the TSC1 and TSC2 gene products. Hum Mol Genet 1998;7:1053–1057.CrossRefPubMedGoogle Scholar
  34. 34.
    Kwiatkowski DJ. Rhebbing up mTor: new insights on TSC1 and TSC2, and the pathogenesis of tuberous sclerosis. Cancer Biol Ther 2003;2:471–476.PubMedGoogle Scholar
  35. 35.
    Franz DN, Leonard J, Tudor C, Chuck G, Care M, Sethuraman G, et al. Rapamycin causes regression of astrocytomas in tuberous sclerosis complex. Ann Neurol 2006;59:490–498.CrossRefPubMedGoogle Scholar
  36. 36.
    Koenig MK, Butler IJ, Northrup H. Regression of subependymal giant cell astrocytoma with rapamycin in tuberous sclerosis complex. J Child Neurol 2008;23:1238–1239.CrossRefPubMedGoogle Scholar
  37. 37.
    Sinson G, Sutton L, Yachnis A. Subependymal giant cell astrocytomas in children. Pediatr Neurosurg 1994;20:233–239.CrossRefPubMedGoogle Scholar
  38. 38.
    Shepherd CW, Scheithauer BW, Gomez MR, Altermatt HJ, Katzmann JA. Subependymal giant cell tumor: a clinical, pathological, and flow cytometric study. Neurosurgery 1991;28:864–868.CrossRefPubMedGoogle Scholar
  39. 39.
    Chow CW, Klug GL, Lewis EA. Subependymal giant-cell astrocytoma in children. An unusual discrepancy between histological and clinical features. J Neurosurg 1988;68:880–883.CrossRefPubMedGoogle Scholar
  40. 40.
    Gyure KA, Prayson RA. Subependymal giant cell astrocytoma: a clinicopathologic study with HMB45 and MIB-1 immunohistochemical analysis. Mod Pathol 1997;10:313–317.PubMedGoogle Scholar
  41. 41.
    Knudson AG Jr. Mutation and cancer: statistical study of retinoblastoma. Proc Natl Acad Sci USA 1971;68:820–823.CrossRefPubMedGoogle Scholar
  42. 42.
    Henske EP, Scheithauer BW, Short MP, Wollmann R, Nahmias J, Hornigold N, et al. Allelic loss is frequent in tuberous sclerosis kidney lesions but rare in brain lesions. Am J Hum Genet 1996;59:400–406.PubMedGoogle Scholar
  43. 43.
    Sepp T, Yates Jr, Green AJ. Loss of heterozygosity in tuberous sclerosis hamartomas. J Med Genet 1996;33:962–964.CrossRefPubMedGoogle Scholar
  44. 44.
    Rakowski SK, Winterkorn EB, Paul E, Steele DJ, Halpern EF, Thiele EA. Renal manifestations of tuberous sclerosis complex: incidence, prognosis, and predictive factors. Kidney Int 2006;70:1777–1782.CrossRefPubMedGoogle Scholar
  45. 45.
    Shepherd CW, Gomez MR, Lie JT, Crowson CS. Causes of death in patients with tuberous sclerosis. Mayo Clin Proc 1991;66:792–796.PubMedGoogle Scholar
  46. 46.
    Henske EP, Neumann HP, Scheithauer BW, Herbst EW, Short MP, Kwiatkowski DJ. Loss of heterozygosity in the tuberous sclerosis (TSC2) region of chromosome band 16p13 occurs in sporadic as well as TSC-associated renal angiomyolipomas. Genes Chromosomes Cancer 1995;13:295–298.CrossRefPubMedGoogle Scholar
  47. 47.
    Han S, Santos TM, Puga A, Roy J, Thiele EA, McCollin M, et al. Phosphorylation of tuberin as a novel mechanism for somatic inactivation of the tuberous sclerosis complex proteins in brain lesions. Cancer Res 2004;64:812–816.CrossRefPubMedGoogle Scholar
  48. 48.
    Carbonara C, Longa L, Grosso E, Borrone C, Garrè MG, Brisigotti M, et al. 9q34 loss of heterozygosity in a tuberous sclerosis astrocytoma suggests a growth suppressor-like activity also for the TSC1 gene. Hum Mol Genet 1994;3:1829–1832.CrossRefPubMedGoogle Scholar
  49. 49.
    Frerebeau PH, Benezech J, Segnarbieux F, Harbi H, Desy A, Marty-Double C. Intraventricular tumors in tuberous sclerosis. Childs Nerv Syst 1985;1:45–48.CrossRefPubMedGoogle Scholar
  50. 50.
    Raju GP, Urion DK, Sahin M. Neonatal subependymal giant cell astrocytoma: new case and review of the literature. Pediatr Neurol 2007;36:128–131.CrossRefPubMedGoogle Scholar
  51. 51.
    Scheithauer BW, Reagan TJ. Neuropathology. In: Gomez MR, Sampson JR, Whittemore VH, eds. Tuberous sclerosis complex: developmental perspectives in psychiatry, 3rd ed. New York: Oxford University Press, 1999:101–144.Google Scholar
  52. 52.
    Nagib MG, Haines SJ, Erickson DL, Mastri AR. Tuberous sclerosis: a review for the neurosurgeon. Neurosurgery 1984;14:93–98.CrossRefPubMedGoogle Scholar
  53. 53.
    Waga S, Yamamoto Y, Kojima T, Sakakura M. Massive haemorrhage in tumor of tuberous sclerosis. Surg Neurol 1977;8:99–101.PubMedGoogle Scholar
  54. 54.
    Fujiwara S, Takaki T, Hikita T, Nishio S. Subependymal giant-cell astrocytoma associated with tuberous sclerosis. Do subependymal nodules grow? Childs Nerv Syst 1989;5:43–44.CrossRefPubMedGoogle Scholar
  55. 55.
    Holanda FJ, Holanda GM. Tuberous sclerosis-neurosurgical indications in intraventricular tumors. Neurosurg Rev 1980;3:139–150.CrossRefPubMedGoogle Scholar
  56. 56.
    Torres OA, Roach ES, Delgado MR, Sparagana SP, Sheffield E, Swift D, et al. Early diagnosis of subependymal giant cell astrocytoma in patients with tuberous sclerosis. J Child Neurol 1998;13:173–177.CrossRefPubMedGoogle Scholar
  57. 57.
    Kumar R, Singh V. Subependymal giant cell astrocytomas: a report of five cases. Neurosurg Rev 2004;27:274–280.PubMedGoogle Scholar
  58. 58.
    Sharma MC, Ralte AM, Gaekwad S, Santosh V, Shankar SK, Sarkar C. Subependymal giant cell astrocytoma—a clinicopathological study of 23 cases with special emphasis on histogenesis. Pathol Oncol Res 2004;10:219–224.CrossRefPubMedGoogle Scholar
  59. 59.
    Osborne JP, Merrifield J, O’Callaghan FJ. Tuberous sclerosis—what’s new? Arch Dis Child 2008;93:728–731.CrossRefPubMedGoogle Scholar
  60. 60.
    Franz DN, de Vries PJ, Crino PB. Giant cell astrocytomas in tuberous sclerosis complex. Arch Dis Child 2008;93:751–754.CrossRefGoogle Scholar

Copyright information

© Children's Hospital, Zhejiang University School of Medicine and Springer-Verlag Berlin Heidelberg 2010

Authors and Affiliations

  1. 1.Department of Neurosurgery B (Unit 501)Pierre Wertheimer HospitalLyonFrance
  2. 2.Claude Bernard Lyon 1 UniversityLyonFrance
  3. 3.Department of Neurosurgery BPierre Wertheimer HospitalLyon Cedex 03France

Personalised recommendations